"The implementation of a new structure for our clinical operations activities will allow us to better meet our clients' needs in international clinical development," says Dr. Andree Beckerling, the CEO of Accovion. "This new structure also supports our aim to achieve greater scale and efficiency and intensify our focus on key markets throughout Europe."
Accovion's activities within International Clinical Operations group have been split into four regions, i.e. Western, Central, Eastern and South-Eastern Europe.
Effective July 15, 2014, Evelyn Hund, as before Director Clinical Project Management at Accovion, took over the position of Director International Clinical Operations within the Accovion Group. Regional Clinical Operations in Western and Central Europe will be directly supervised by Ms. Hund. Within these regions she will be supported by a Deputy Head of International Clinical Operations, two Heads of Clinical Monitoring and a Head of Clinical Trial Regulatory Management (CTRM).
At the same time Dr. Łukasz Sobiak, Country Director of Accovion Poland, has been appointed as Regional Director Clinical Operations for Eastern and South-Eastern Europe. In this function, Dr. Sobiak will be responsible for direct oversight of all clinical operations activities, including Clinical Project Management, Monitoring and Clinical Trial Regulatory Management activities in this region. He will be supported by a Head of Monitoring as well as a CTRM team for the region.
All Accovion members of the local clinical teams will be operationally integrated in this new regional structure.
"With our strong and growing international team and our new structure for clinical operations we will focus on future growth in Europe," emphasizes Dr. Beckerling.
Accovion, headquartered in Frankfurt (Eschborn), Germany, is a leading independent European full-service Contract Research Organization. The company provides the entire range of clinical research services to the pharmaceutical, biotechnology and medical device industries and is currently active in more than 20 countries.